Search for Clinical Trial Results

Sponsored By

Huntington Disease - 28 Studies Found

Status Study
Completed Study Name: Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Date: 2011-12-29
Interventions:
  • Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

Completed Study Name: A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Date: 2008-07-24
Interventions:
  • Drug: ACR16 10 mg ACR16 capsul
Completed Study Name: Pilot Study of Minocycline in Huntington's Disease
Condition: Huntington Disease
Date: 2006-01-12
Interventions:
  • Drug: minocycline Minocycline:
Completed Study Name: A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington's Disease
Condition: Huntington's Disease
Date: 2008-04-22
Interventions:
  • Drug: ACR16 45 mg capsules Cap
Active, not recruiting Study Name: Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Date: 2011-02-28
Interventions: Drug: pridopidine 45mg bid
Active, not recruiting Study Name: Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
Condition: Huntington Disease
Date: 2003-01-08
Completed Study Name: Creatine Therapy for Huntington's Disease
Condition: Huntington's Disease
Date: 2001-11-15
Interventions: Drug: Creatine
Completed Study Name: A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Condition: Huntington's Disease
Date: 2007-07-03
Interventions:
  • Other: Placebo Placebo TID x 9
Completed Study Name: Bioavailability of Ubiquinol in Huntington Disease
Condition: Huntington Disease
Date: 2009-09-17
Interventions: Dietary Supplement: ubiquinol up to 600 mg per day, oral capsules for 8 weeks
Completed Study Name: Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
Condition: Huntington Disease
Date: 2012-03-11
Next >>>